Inventor · disambiguated record
Timothy M. Fan
Also filed as: FAN TIMOTHY M
16 granted patents·4 pending applications·68 citations·filing 2010–2023
92Inventor score
Top patents by PatentIndex Score
20 records- 0189US9102661B2Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugsUNIV ILLINOIS·Filed 2014·Granted Aug 11, 2015·15 cites·27 claims
- 0286US12433885B2Procaspase combination therapy for glioblastomaUNIV ILLINOIS·Filed 2023·Granted Oct 7, 2025·0 cites·16 claims
- 0386US9643960B2Procaspase activating compoundsUNIV ILLINOIS·Filed 2015·Granted May 9, 2017·7 cites·21 claims
- 0486US9421202B2Procaspase combination therapy for glioblastomaHERGENROTHER PAUL J·Filed 2013·Granted Aug 23, 2016·9 cites·20 claims
- 0586US9399035B2Procaspase 3 activation by combination therapyHERGENROTHER PAUL J·Filed 2013·Granted Jul 26, 2016·8 cites·5 claims
- 0685US8778945B2Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugsHERGENROTHER PAUL JOSEPH·Filed 2010·Granted Jul 15, 2014·17 cites·16 claims
- 0784US10888560B2Procaspase 3 activation by combination therapyUNIV ILLINOIS·Filed 2018·Granted Jan 12, 2021·1 cites·10 claims
- 0884US9592229B2Potent anticancer activity via dual compound activationUNIV ILLINOIS·Filed 2013·Granted Mar 14, 2017·8 cites·21 claims
- 0977US10874666B2Procaspase combination therapy for glioblastomaUNIV ILLINOIS·Filed 2018·Granted Dec 29, 2020·1 cites·12 claims
- 1075US10085978B2Procaspase combination therapy for glioblastomaUNIV ILLINOIS·Filed 2016·Granted Oct 2, 2018·1 cites·10 claims
- 1174US11844798B2Procaspase combination therapy for glioblastomaUNIV ILLINOIS·Filed 2020·Granted Dec 19, 2023·0 cites·6 claims
- 1274US11833147B2Procaspase 3 activation by combination therapyUNIV ILLINOIS·Filed 2021·Granted Dec 5, 2023·0 cites·6 claims
- 1374US10085977B2Procaspase 3 activation by combination therapyUNIV ILLINOIS·Filed 2016·Granted Oct 2, 2018·1 cites·18 claims
- 1471US12234240B2Substituted imidazo[5,1-d][1,2,3,5]tetrazines for the treatment of cancerUNIV ILLINOIS·Filed 2022·Granted Feb 25, 2025·0 cites·13 claims
- 1564US2021315886A1Imidazotetrazine compoundsUNIV ILLINOIS·Filed 2019·Application pending·0 cites
- 1662US11530457B2Saliva-based molecular testing for SARS-CoV-2UNIV ILLINOIS·Filed 2021·Granted Dec 20, 2022·0 cites·4 claims
- 1761US11926877B2Saliva-based molecular testing for SARS-CoV-2UNIV ILLINOIS·Filed 2021·Granted Mar 12, 2024·0 cites·18 claims
- 1860US2021002286A1Imidazotetrazine compoundsUNIV ILLINOIS·Filed 2020·Application pending·0 cites
- 1958US2025129083A1Imidazotetrazine compounds and treatment of tmz-resistant cancersUNIV ILLINOIS·Filed 2023·Application pending·0 cites
- 2048US2022226311A1Procaspase-3 activation and immunotherapy for treatment of cancerUNIV ILLINOIS·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Timothy M. Fan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →